5-氯-1,3-二甲基-1H-吡唑-4-甲酸 | 27006-82-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 5-氯-1,3-二甲基-1H-吡唑-4-甲酸
• 中文别名: 5-氯-1,3-二甲基-1H-吡唑-4-羧酸
• 英文名称: 5-chloro-1,3-dimethylpyrazole-4-carboxylic acid
• 英文别名: 1,3-Dimethyl-5-chlor-pyrazol-4-carbonsaeure；5-chloro-1,3-dimethyl-4-pyrazolecarboxylic acid；5-chloro-1,3-dimethyl-1H-pyrazole-4-carboxylic acid
• CAS: 27006-82-2
• 化学式: C₆H₇ClN₂O₂
• mdl: MFCD00232043
• 分子量: 174.587
• InChiKey: RRWQERXMLIEDKJ-UHFFFAOYSA-N

物化性质

• 熔点：
  195 °C
• 沸点：
  316.1±37.0 °C(Predicted)
• 密度：
  1.47±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  55.1
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2933199090

SDS

Name:	5-Chloro-1 3-dimethyl-1h-pyrazole-4-carboxylic acid 97% Material Safety Data Sheet
Synonym:
CAS:	27006-82-2

Section 1 - Chemical Product MSDS Name:5-Chloro-1 3-dimethyl-1h-pyrazole-4-carboxylic acid 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
27006-82-2	5-Chloro-1,3-dimethyl-1H-pyrazole-4-ca	97%	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 27006-82-2: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white crystalline solid
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 198 - 199 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C6H7ClN2O2
Molecular Weight: 174.59

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 27006-82-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
5-Chloro-1,3-dimethyl-1H-pyrazole-4-carboxylic acid - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 27006-82-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 27006-82-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 27006-82-2 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-氯-1,3-二甲基-1H-吡唑-4-甲酸 在 palladium on activated charcoal 氢气 、 sodium carbonate 作用下， 以 水 为溶剂， 以93%的产率得到1,3-二甲基-1H-吡唑-4-羧酸
  参考文献：
  名称：

  Systemic fungicides. The synthesis of certain pyrazole analogues of carboxin

  摘要：

  介绍了 1,3-二甲基-N-苯基吡唑-4-甲酰胺（3）和异构体 1,5-二甲基化合物（4）的合成方法。 1,3-二甲基-N-苯基吡唑-4-甲酰胺（3）和异构体 1,5-二甲基化合物（4）的合成方法。 羧菌素的结构类似物。本文提出了证实这些化合物结构归属的证据，并介绍了一种简便的 并介绍了从一些氨基吡唑中去除氨基的简便方法。 基的简便方法。

  DOI：

  10.1071/ch9830135
• 作为产物：
  描述：

  1,3-二甲基-5-吡唑酮 在 potassium permanganate 、 三氯氧磷 作用下， 以 水 为溶剂， 生成 5-氯-1,3-二甲基-1H-吡唑-4-甲酸
  参考文献：
  名称：

  新型针对琥珀酸脱氢酶的抗真菌药物的权宜之计：带有二苯醚片段的吡唑-4-甲酰肼衍生物

  摘要：

  含有柔性酰胺链的吡唑-4-羧酰胺支架已经成为靶向琥珀酸脱氢酶（SDH）的高效农业杀菌剂的分子骨架。基于上述琥珀酸脱氢酶抑制剂（SDHI）的重要结构特征，在生物活性分子与SDH之间的虚拟对接比较的指导下，合理构思了三种新型的带有联苯醚部分的吡唑-4-甲酰肼衍生物。与分子对接比较的虚拟验证结果一致，体外抗真菌生物测定表明，标题化合物的骨架结构应优化为N '-（4-苯氧基苯基）-1 H-吡唑-4-碳酰肼支架。惊人地N '-（4-苯氧基苯基）-1 H-吡唑-4-碳酰肼衍生物对solani solani的影响11o，对禾谷镰刀菌（Fusarium graminearum）的11m和对灰葡萄孢的11g表现出优异的抗真菌作用，相应的EC 50值为0.14、0.27和0.52 μg/ mL，明显优于多菌灵（针对多菌灵（0.34μg / mL）和禾本科镰刀菌（0.57μg/ mL））和戊硫吡拉（对灰霉病）（0

  DOI：

  10.1021/acs.jafc.0c03736

文献信息

• Design, synthesis, antifungal activity and 3D-QSAR study of novel pyrazole carboxamide and niacinamide derivatives containing benzimidazole moiety
  作者：Wei-Jie Si、Xiao-Bin Wang、Min Chen、Meng-Qi Wang、Ai-Min Lu、Chun-Long Yang

  DOI：10.1039/c8nj05150j

  日期：——

  series of novel pyrazole carboxamide and niacinamide derivatives containing a benzimidazole moiety were designed and synthesized as antifungal candidate agents. All target compounds were characterized by FTIR, 1H NMR, 13C NMR, HRMS and elemental analysis techniques. The structure of compound T1 was further confirmed by single crystal X-ray diffraction analysis. The antifungal activities of the target

  设计并合成了一系列含有苯并咪唑部分的新型吡唑羧酰胺和烟酰胺衍生物，作为抗真菌候选药物。所有目标化合物均通过FTIR，1 H NMR，13 C NMR，HRMS和元素分析技术进行了表征。化合物T1的结构通过单晶X射线衍射分析进一步确认。在体外评估了目标化合物对四种植物病原真菌（灰葡萄孢，立枯根瘤菌，禾谷镰刀菌和黑斑病菌）的抗真菌活性。）通过菌丝体生长抑制方法。生物测定结果表明，一些化合物对显示出良好的抗真菌活性灰霉病以100μgML -1相比其他三个真菌。为了更好地探索结构-活性关系（SAR），测定并评估了目标化合物对灰葡萄孢的EC 50值。随后，基于被测化合物对灰葡萄孢的抑制活性，使用比较分子场分析（CoMFA）技术进行了3D定量结构-活性关系（3D-QSAR）研究。分子建模结果显示具有交叉验证的q 2的良好预测能力和非交叉验证的r 2值分别为0.578和0.850。
• Kinase Inhibitors
  申请人：Wurster A. Julie

  公开号：US20070032478A1

  公开（公告）日：2007-02-08

  The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.

  本发明涉及有机分子，能够调节酪氨酸激酶信号传导，以调节、调控和/或抑制异常细胞增殖。
• [EN] THIAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS<br/>[FR] COMPOSÉS THIAZOLIDINES EN TANT QU'ANTAGONISTES DES RÉCEPTEURS DE L'OREXINE
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2010004507A1

  公开（公告）日：2010-01-14

  The invention relates to thiazolidine derivatives of the formula (I) wherein A, B, and R1 are as described in the description, to salts, especially pharmaceutically acceptable salts, of such compounds and to their use as medicaments, especially as orexin receptor antagonists.

  这项发明涉及式(I)的噻唑啉衍生物，其中A、B和R1如描述中所述，以及这些化合物的盐，特别是药学上可接受的盐，以及它们作为药物的用途，特别是作为促进睡眠的药物受体拮抗剂。
• Adamantyl-pyrazole carboxamides as inhibitors of 11B-hydroxysteroid dehydrogenase
  申请人：Anderson Kevin William

  公开号：US20070225280A1

  公开（公告）日：2007-09-27

  Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.

  本文提供了以下式（I）的化合物： 以及其药学上可接受的盐，其中取代基如规范中所披露的那样。这些化合物及含有它们的药物组合物对于治疗诸如II型糖尿病和代谢综合征等疾病是有用的。
• 3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
  申请人：Aissaoui Hamed

  公开号：US20100016401A1

  公开（公告）日：2010-01-21

  The invention relates to 3-aza-bicyclo[3.1.0]hexane derivatives of formula (I) wherein A, B, n, X, and R 1 are as described in the description, and salts thereof, and their use as orexin receptor antagonists.

  这项发明涉及式(I)的3-aza-双环[3.1.0]己烷衍生物，其中A、B、n、X和R1如描述中所述，以及其盐，以及它们作为促进睡眠的荷尔蒙受体拮抗剂的用途。